KR20120005111A - Athletic ability enhancing composition comprising licorice extracts and preparation method thereof - Google Patents
Athletic ability enhancing composition comprising licorice extracts and preparation method thereof Download PDFInfo
- Publication number
- KR20120005111A KR20120005111A KR1020100065690A KR20100065690A KR20120005111A KR 20120005111 A KR20120005111 A KR 20120005111A KR 1020100065690 A KR1020100065690 A KR 1020100065690A KR 20100065690 A KR20100065690 A KR 20100065690A KR 20120005111 A KR20120005111 A KR 20120005111A
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- licorice
- composition
- hot water
- ethanol
- Prior art date
Links
- 239000000284 extract Substances 0.000 title claims abstract description 88
- 239000000203 mixture Substances 0.000 title claims abstract description 48
- 230000002708 enhancing effect Effects 0.000 title claims abstract description 14
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 title claims description 16
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 title claims description 16
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 title claims description 16
- 229940010454 licorice Drugs 0.000 title claims description 16
- 230000000386 athletic effect Effects 0.000 title claims description 6
- 238000002360 preparation method Methods 0.000 title description 2
- 240000004670 Glycyrrhiza echinata Species 0.000 title 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 31
- 238000000034 method Methods 0.000 claims abstract description 25
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 25
- 239000004480 active ingredient Substances 0.000 claims abstract description 19
- 239000002244 precipitate Substances 0.000 claims abstract description 12
- 238000002481 ethanol extraction Methods 0.000 claims abstract description 11
- 238000000194 supercritical-fluid extraction Methods 0.000 claims abstract description 10
- LBQIJVLKGVZRIW-UHFFFAOYSA-N glabridine Natural products C1OC2=C3C=CC(C)(C)OC3=CC=C2CC1C1=CC=C(O)C=C1O LBQIJVLKGVZRIW-UHFFFAOYSA-N 0.000 claims abstract description 9
- 238000002156 mixing Methods 0.000 claims abstract description 5
- 238000003809 water extraction Methods 0.000 claims abstract description 5
- 229940069445 licorice extract Drugs 0.000 claims description 42
- 241000202807 Glycyrrhiza Species 0.000 claims description 15
- 230000037147 athletic performance Effects 0.000 claims description 15
- 238000000605 extraction Methods 0.000 claims description 14
- 239000000469 ethanolic extract Substances 0.000 claims description 12
- 239000002904 solvent Substances 0.000 claims description 9
- 229960004949 glycyrrhizic acid Drugs 0.000 claims description 8
- 235000019410 glycyrrhizin Nutrition 0.000 claims description 8
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims description 8
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 claims description 7
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 claims description 7
- 239000004378 Glycyrrhizin Substances 0.000 claims description 6
- 230000008569 process Effects 0.000 claims description 6
- 240000008917 Glycyrrhiza uralensis Species 0.000 abstract 5
- 235000000554 Glycyrrhiza uralensis Nutrition 0.000 abstract 5
- 240000000745 Erythronium japonicum Species 0.000 abstract 1
- 235000000495 Erythronium japonicum Nutrition 0.000 abstract 1
- LBQIJVLKGVZRIW-ZDUSSCGKSA-N glabridin Chemical compound C1([C@H]2CC3=CC=C4OC(C=CC4=C3OC2)(C)C)=CC=C(O)C=C1O LBQIJVLKGVZRIW-ZDUSSCGKSA-N 0.000 abstract 1
- 229940093767 glabridin Drugs 0.000 abstract 1
- PMPYOYXFIHXBJI-ZDUSSCGKSA-N glabridin Natural products C1([C@H]2CC=3C=CC4=C(C=3OC2)CCC(O4)(C)C)=CC=C(O)C=C1O PMPYOYXFIHXBJI-ZDUSSCGKSA-N 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 25
- 210000003205 muscle Anatomy 0.000 description 16
- 235000009200 high fat diet Nutrition 0.000 description 11
- 229920002527 Glycogen Polymers 0.000 description 10
- 210000004369 blood Anatomy 0.000 description 10
- 239000008280 blood Substances 0.000 description 10
- 229940096919 glycogen Drugs 0.000 description 10
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 10
- 230000008859 change Effects 0.000 description 9
- 239000003925 fat Substances 0.000 description 9
- 230000001965 increasing effect Effects 0.000 description 9
- 210000004185 liver Anatomy 0.000 description 9
- 230000007423 decrease Effects 0.000 description 8
- 230000003247 decreasing effect Effects 0.000 description 8
- 235000013361 beverage Nutrition 0.000 description 7
- 235000005911 diet Nutrition 0.000 description 7
- 239000000796 flavoring agent Substances 0.000 description 7
- 150000002632 lipids Chemical class 0.000 description 7
- 239000003550 marker Substances 0.000 description 7
- 241000699670 Mus sp. Species 0.000 description 6
- 210000003486 adipose tissue brown Anatomy 0.000 description 6
- 235000013305 food Nutrition 0.000 description 6
- 230000002440 hepatic effect Effects 0.000 description 6
- 210000001789 adipocyte Anatomy 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 239000004310 lactic acid Substances 0.000 description 5
- 235000014655 lactic acid Nutrition 0.000 description 5
- 230000004584 weight gain Effects 0.000 description 5
- 235000019786 weight gain Nutrition 0.000 description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 230000037213 diet Effects 0.000 description 4
- 235000018823 dietary intake Nutrition 0.000 description 4
- 201000010063 epididymitis Diseases 0.000 description 4
- 235000013355 food flavoring agent Nutrition 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- DRCWOKJLSQUJPZ-DZGCQCFKSA-N (4ar,9as)-n-ethyl-1,4,9,9a-tetrahydrofluoren-4a-amine Chemical compound C1C2=CC=CC=C2[C@]2(NCC)[C@H]1CC=CC2 DRCWOKJLSQUJPZ-DZGCQCFKSA-N 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 101001008429 Homo sapiens Nucleobindin-2 Proteins 0.000 description 3
- 208000029549 Muscle injury Diseases 0.000 description 3
- 102100027441 Nucleobindin-2 Human genes 0.000 description 3
- 102000013394 Troponin I Human genes 0.000 description 3
- 108010065729 Troponin I Proteins 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 230000003579 anti-obesity Effects 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 230000000378 dietary effect Effects 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 230000001681 protective effect Effects 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- 208000031648 Body Weight Changes Diseases 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 208000004930 Fatty Liver Diseases 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 206010019708 Hepatic steatosis Diseases 0.000 description 2
- 108010028554 LDL Cholesterol Proteins 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 2
- 102000016267 Leptin Human genes 0.000 description 2
- 108010092277 Leptin Proteins 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- DRBBFCLWYRJSJZ-UHFFFAOYSA-N N-phosphocreatine Chemical compound OC(=O)CN(C)C(=N)NP(O)(O)=O DRBBFCLWYRJSJZ-UHFFFAOYSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 230000004579 body weight change Effects 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 235000015872 dietary supplement Nutrition 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 208000010706 fatty liver disease Diseases 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- 235000013373 food additive Nutrition 0.000 description 2
- 239000002778 food additive Substances 0.000 description 2
- 235000015203 fruit juice Nutrition 0.000 description 2
- 230000014509 gene expression Effects 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- NRYBAZVQPHGZNS-ZSOCWYAHSA-N leptin Chemical compound O=C([C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC(C)C)CCSC)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(O)=O NRYBAZVQPHGZNS-ZSOCWYAHSA-N 0.000 description 2
- 229940039781 leptin Drugs 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 210000005228 liver tissue Anatomy 0.000 description 2
- 235000021590 normal diet Nutrition 0.000 description 2
- 230000036314 physical performance Effects 0.000 description 2
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 2
- 230000036387 respiratory rate Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 231100000240 steatosis hepatitis Toxicity 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 235000013616 tea Nutrition 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 239000001512 FEMA 4601 Substances 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 108010023302 HDL Cholesterol Proteins 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 229920002230 Pectic acid Polymers 0.000 description 1
- HELXLJCILKEWJH-SEAGSNCFSA-N Rebaudioside A Natural products O=C(O[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)[C@@]1(C)[C@@H]2[C@](C)([C@H]3[C@@]4(CC(=C)[C@@](O[C@H]5[C@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@H](O)[C@@H](CO)O5)(C4)CC3)CC2)CCC1 HELXLJCILKEWJH-SEAGSNCFSA-N 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 210000000593 adipose tissue white Anatomy 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 238000007707 calorimetry Methods 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000022534 cell killing Effects 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 210000000028 corpus adiposum pararenale Anatomy 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- HELXLJCILKEWJH-UHFFFAOYSA-N entered according to Sigma 01432 Natural products C1CC2C3(C)CCCC(C)(C(=O)OC4C(C(O)C(O)C(CO)O4)O)C3CCC2(C2)CC(=C)C21OC(C1OC2C(C(O)C(O)C(CO)O2)O)OC(CO)C(O)C1OC1OC(CO)C(O)C(O)C1O HELXLJCILKEWJH-UHFFFAOYSA-N 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000037080 exercise endurance Effects 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 230000002414 glycolytic effect Effects 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 239000006049 herbal material Substances 0.000 description 1
- 230000006882 induction of apoptosis Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229940126601 medicinal product Drugs 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 210000000107 myocyte Anatomy 0.000 description 1
- 210000001087 myotubule Anatomy 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 239000012454 non-polar solvent Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid group Chemical group C(CCCCCCC\C=C/CCCCCCCC)(=O)O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- -1 pH adjusters Substances 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- LCLHHZYHLXDRQG-ZNKJPWOQSA-N pectic acid Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](C(O)=O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](OC2[C@@H]([C@@H](O)[C@@H](O)[C@H](O2)C(O)=O)O)[C@@H](C(O)=O)O1 LCLHHZYHLXDRQG-ZNKJPWOQSA-N 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 239000010318 polygalacturonic acid Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 235000019203 rebaudioside A Nutrition 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/316—Foods, ingredients or supplements having a functional effect on health having an effect on regeneration or building of ligaments or muscles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/37—Extraction at elevated pressure or temperature, e.g. pressurized solvent extraction [PSE], supercritical carbon dioxide extraction or subcritical water extraction
Abstract
Description
본 발명은 감초 추출물을 유효성분으로 함유하는 조성물에 관한 것으로, 보다 상세하게는 감초 추출물을 함유하는 지구력 내지 운동능력 증진용 조성물 및 제조방법으로, 특히 이러한 기능과 관련되는 것으로 판단되는 유효성분들의 함량을 극대화하여 지구력 내지 운동능력에 보다 탁월한 효과를 제공하는 조성물 및 그 제조방법에 관한 것이다.
The present invention relates to a composition containing licorice extract as an active ingredient, and more particularly, to a composition and a manufacturing method for improving endurance or athletic performance containing licorice extract, in particular the content of the effective ingredients determined to be related to this function To maximize the composition to provide a more excellent effect on endurance to exercise ability and to a method for producing the same.
육체적 운동능력을 향상시키기 위한 보조제, 기능성 식품, 식품 조성물 등의 연구는 오랫동안 지속되어 왔으며 실제로 스테로이드, 카페인 등등의 화합물을 복용하면 운동능력을 증가시킬 수도 있다. 그러나 이러한 약물은 치명적인 부작용을 동반할 수 있으므로 극히 그 사용이 제한되고 있는 것이 사실이다.Research into supplements, functional foods, food compositions, etc., to improve physical performance has been ongoing for a long time, and in fact, taking compounds such as steroids, caffeine, etc. may increase athletic performance. However, since these drugs can have fatal side effects, their use is extremely limited.
감초는 예로부터 식품의 조미료나 약용으로서 사용되어 왔으며, 특히 주성분인 글리시리진(Glycyrrhizin)은 자당의 150배의 감도가 있으며, 감미료로서 현재에도 널리 사용되고 있다. 한편으로, 감초 추출물에는 항궤양 작용(Takagi, K., Ishii, Y. : Arzein Forsch, 17, 1544 (1967)) 이나 간 장해 보호 작용 등의 약리 작용이 있다는 것이 알려져 있다.Licorice has long been used as a seasoning and medicinal product. Especially, glycyrrhizin, the main ingredient, has 150 times the sensitivity of sucrose and is still widely used as a sweetener. On the other hand, it is known that licorice extract has pharmacological effects such as anti-ulcer action (Takagi, K., Ishii, Y .: Arzein Forsch, 17, 1544 (1967)) or hepatic protective effect.
감초의 이와 같은 다양한 효과에 관한 연구들이 있어 왔지만, 육체적 운동능력에 대한 증진 효과에 관하여는 알려진 바가 없다. 본 발명에서는 종래 한방재료로서 치명적인 부작용이 없으면서 지구력 내지 운동능력 증진의 개선효과가 뚜렷한 천연소재를 찾던 중 감초의 추출물이 이러한 요구를 만족할 수 있음을 발견하여 본 발명에 이르게 되었다.
There have been studies on these various effects of licorice, but there is no known effect on the enhancement of physical performance. In the present invention, it was found that the extract of licorice can satisfy this requirement while looking for a natural material having a marked improvement in endurance to exercise ability improvement without fatal side effects as a conventional herbal material.
본 발명은 상기한 바와 같이 종래 기술이 가지는 이러한 과제를 해결하기 위해 안출된 것으로, 그 목적은 감초 추출물을 함유하는 지구력 내지 운동능력 증진용 조성물 및 제조방법을 제공함에 있다.The present invention has been made to solve the above problems with the prior art as described above, the object is to provide a composition and method for improving endurance to athletic performance containing licorice extract.
본 발명의 다른 목적으로는 특히 지구력 내지 운동능력 증진과 관련되는 것으로 판단되는 유효성분들의 함량을 극대화하여 지구력 내지 운동능력에 보다 탁월한 효과를 제공하는 조성물 및 그 제조방법을 제공함에 있다.
Another object of the present invention is to provide a composition and a method for producing the same, which provide a more excellent effect on endurance to exercise ability by maximizing the content of the active ingredients, which are determined to be related to endurance to exercise ability.
상기한 바와 같은 본 발명의 기술적 과제는 다음과 같은 수단에 의해 달성되어진다.The technical problem of the present invention as described above is achieved by the following means.
(1) 감초 추출물을 유효성분으로 함유하는 지구력 내지 운동능력 증진용 조성물.(1) a composition for improving endurance to exercise ability containing licorice extract as an active ingredient.
(2) 제 1항에 있어서,(2) The method according to
감초 추출물은 열수 추출물인 것을 특징으로 하는 지구력 내지 운동능력 증진용 조성물.Licorice extract is a composition for enhancing endurance to athletic performance, characterized in that the hot water extract.
(3) 제 1항에 있어서,(3) The method according to
감초 추출물은 에탄올 추출물 또는 에탄올을 추출용매로 하는 초임계 추출물인 것을 특징으로 하는 지구력 내지 운동능력 증진용 조성물.Licorice extract is a composition for enhancing endurance or athletic performance, characterized in that the supercritical extract using an ethanol extract or ethanol as an extract solvent.
(4) 제 1항에 있어서,(4) The method according to 1,
감초 추출물은 열수 추출물과, 상기 열수추출과정에서 얻어진 침전물을 대상으로 하는 에탄올 추출물의 혼합물인 것을 특징으로 하는 지구력 내지 운동능력 증진용 조성물.Licorice extract is a composition for enhancing endurance or athletic ability, characterized in that the mixture of hot water extract and ethanol extract for the precipitate obtained in the hot water extraction process.
(5) 제 1항에 있어서,(5) The method according to
감초 추출물은 에탄올 추출물과, 상기 에탄올 추출과정에서 얻어진 침전물의 열수추출물로 이루어지는 혼합물인 것을 특징으로 하는 지구력 내지 운동능력 증진용 조성물.Licorice extract is a composition for improving endurance to athletic performance, characterized in that the mixture consisting of ethanol extract, and hot water extract of the precipitate obtained in the ethanol extraction process.
(6) 제 1항에 있어서,(6) The method according to 1,
얼레지 추출물을 더 포함하는 것을 특징으로 하는 지구력 내지 운동능력 증진용 조성물.Composition for improving endurance to athleticism, characterized in that it further comprises an extract.
(7) 감초를 열수로 추출하여 글리시리진을 활성성분으로 주로 함유하는 제1추출물을 얻는 단계;(7) extracting licorice with hot water to obtain a first extract containing mainly glycyrizine as an active ingredient;
상기 열수 추출과정에서 얻어진 침전물을 에탄올추출 또는 초임계 추출하여 글라브리딘을 활성성분으로 주로 함유하는 제2추출물을 얻는 단계; 및Ethanol extraction or supercritical extraction of the precipitate obtained in the hydrothermal extraction process to obtain a second extract containing mainly glabridine as an active ingredient; And
상기 제1추출물과 제2추출물을 혼합하는 단계;Mixing the first extract and the second extract;
를 포함하는 지구력 내지 운동능력 증진용 감초추출물의 제조방법.Method of producing a licorice extract for improving endurance or athletic performance comprising a.
(8) 감초를 에탄올 추출 또는 초임계 추출하여 글라브리딘을 활성성분으로 주로 함유하는 제1추출물을 얻는 단계;(8) ethanol extraction or supercritical extraction of licorice to obtain a first extract containing mainly glabridine as an active ingredient;
상기 에탄올 추출과정에서 얻어진 침전물을 열수로 추출하여 글리시리진을 활성성분으로 주로 함유하는 제2추출물을 얻는 단계; 및Extracting the precipitate obtained in the ethanol extraction process with hot water to obtain a second extract mainly containing glycyrrhizin as an active ingredient; And
상기 제1추출물과 제2추출물을 혼합하는 단계;Mixing the first extract and the second extract;
를 포함하는 지구력 내지 운동능력 증진용 감초추출물의 제조방법.
Method of producing a licorice extract for improving endurance or athletic performance comprising a.
상기 실시 예에서 상세히 기술한 바와 같이, 본 발명에 따른 감초 추출물을 함유하는 조성물은 기존에 알려진 일반적인 기능 외에 지구력 내지 운동능력을 개선하는 효과를 제공한다. 특히 이러한 기능과 관련되는 것으로 판단되는 유효성분들의 함량을 극대화하여 지구력 내지 운동능력에 보다 탁월한 효과를 제공하는 조성물을 제공할 수 있다.As described in detail in the above embodiment, the composition containing the licorice extract according to the present invention provides the effect of improving endurance or exercise ability in addition to the conventional known functions. In particular, by maximizing the content of the active ingredients determined to be related to such a function can provide a composition that provides a more excellent effect on endurance to exercise ability.
도 1은 감초를 대상으로 하는 추출용매별 HPLC 분석 크로마토그램.
도 2는 감초를 대상으로 하는 추출조건에 따른 기능성분 함유량 변화.
도 3은 감초 추출물 종류별 고지방 식이 급여 운동 마우스의 체중증가에 미치는 영향을 측정한 결과.
도 4는 본 발명에 따른 추출물을 이용하여 실험한 실험군별 체중 증가량을 측정한 결과.
도 5는 본 발명에 따른 추출물을 이용하여 실험한 마우스의 일별 평균 식이 섭취량을 측정한 결과.
도 6은 본 발명에 따른 추출물을 이용하여 실험한 실험 식이 급여 6, 9주 후 운동 지구력 시험 결과.
도 7은 본 발명에 따른 감초 추출물 급여의 종류에 따른 마우스의 장기무게 비교.
도 8은 본 발명에 따른 추출물을 이용하여 실험한 간, 백색지방 및 갈색지방의 조직학적 분석결과.
도 9는 본 발명에 따른 추출물을 이용하여 실험한 혈중 지질 변화를 측정한 결과.
도 10은 본 발명에 따른 추출물을 이용하여 실험한 간조직 내 총 지방량, TC 및 TG 변화.
도 11은 본 발명에 따른 추출물을 이용하여 실험한 간의 CPK 와 글리코겐 함량 변화.
도 12는 본 발명에 따른 추출물을 이용하여 실험한 근육의 젖산과 글리코겐 함량 변화
도 13은 본 발명에 따른 추출물을 이용하여 실험한 근육의 젖산과 glycogen 함량 변화
도 14는 본 발명에 따른 추출물을 이용하여 지근 (slow and aerobic type I muscle) 마커인 트로포닌 I(troponin I)과 속근 마커인 MyHCIIb의 유전자 발현을 측정한 결과 .
도 15는 본 발명에 따른 감초추출물과 얼레지추출물의 혼합적용에 의한 지방세포 사멸효과를 측정한 결과.1 is an HPLC analysis chromatogram for each extract using licorice.
2 is a functional component content change according to the extraction conditions for licorice.
Figure 3 is the result of measuring the effect on weight gain of high-fat dietary feeding exercise mouse by licorice extract type.
Figure 4 is the result of measuring the weight gain by experimental group experimented with the extract according to the present invention.
Figure 5 is the result of measuring the average daily dietary intake of mice experimented with the extract according to the present invention.
6 is an exercise
Figure 7 is a comparison of the long-term weight of the mouse according to the type of licorice extract feed according to the present invention.
Figure 8 is the histological analysis of liver, white fat and brown fat tested using the extract according to the present invention.
Figure 9 is the result of measuring the blood lipid change experimented using the extract according to the present invention.
10 is a change in total fat, TC and TG in liver tissues tested using the extract according to the present invention.
11 is a change in CPK and glycogen content of the liver experimented with the extract according to the present invention.
Figure 12 is the change in lactate and glycogen content of muscle tested using the extract according to the present invention
Figure 13 changes in lactate and glycogen content in muscle tested using the extract according to the present invention
Figure 14 is a result of measuring the gene expression of the troponin I (slow and aerobic type I muscle) marker troponin I and the muscle root marker MyHCIIb using the extract according to the present invention.
15 is a result of measuring the fat cell killing effect by the mixed application of licorice extract and ulge extract according to the present invention.
이하 본 발명의 내용을 보다 상세하게 설명하면 다음과 같다.Hereinafter, the content of the present invention will be described in detail.
본 발명은 감초 추출물을 유효성분으로 함유하는 지구력 내지 운동능력 증진용 조성물을 포함한다.The present invention includes a composition for improving endurance to athletic performance containing licorice extract as an active ingredient.
상기 본 발명 조성물에서의 감초 추출물은 열수 추출물, 에탄올 추출물(물과의 혼합물을 포함, 이하 별도의 언급이 없는 한 에탄올 추출물로 통칭함), 초임계 추출물 또는 이들 추출물의 혼합물을 포함한다.Licorice extract in the composition of the present invention includes a hot water extract, ethanol extract (including a mixture with water, hereinafter referred to as ethanol extract unless otherwise specified), supercritical extract or a mixture of these extracts.
열수 추출물의 경우 1∼10배의 물을 가하여 1 내지 2기압, 80∼120℃하에 1∼12시간 추출하는 것이 바람직하다. 에탄올 추출물의 경우 50 내지 100% 에탄올로 이루어진 추출용매를 이용할 수 있고, 초임계 추출물은 에탄올을 추출용매로 하여 250 내지 350bar의 압력하에 수행되어질 수 있다.In the case of hot water extract, it is preferable to add 1-10 times of water, and to extract for 1 to 12 hours under 1-2 atm and 80-120 degreeC. In the case of the ethanol extract, an extraction solvent consisting of 50 to 100% ethanol may be used, and the supercritical extract may be performed under a pressure of 250 to 350 bar using ethanol as the extraction solvent.
본 발명 조성물에서의 감초 추출물은 글리시리진 또는/및 글라브리딘을 주 활성성분으로 함유하며, 이들은 아직 밝혀지지 않은 기작에 의해 직ㆍ간접적으로 각각 지구력 강화 내지 운동능력 증진에 기여하는 것으로 판단된다. 본 발명에서는 이들 성분들을 함유하는 감초 추출물이 열수 추출물의 형태일 경우 주로 글리시리진이 다량으로 함유되며, 에탄올 추출물과 초임계 추출물에서는 글라브리딘이 주성분으로 함유되는 것을 확인하였으며, 각 추출물 모두에서 지구력 강화 내지 운동능력 증진에 탁월한 효과를 발휘하는 것을 확인하였다.Licorice extract in the composition of the present invention contains glycyrrhizin and / or glabridine as the main active ingredients, and these are judged to contribute to strengthening endurance or enhancing athletic ability, respectively, directly and indirectly by mechanisms that have not yet been identified. In the present invention, when the licorice extract containing these components is in the form of a hydrothermal extract, glycyrrazine is mainly contained in a large amount, and the ethanol extract and the supercritical extract have been found to contain glabridine as a main component, and strengthening endurance in each extract. It was confirmed to exert an excellent effect on the enhancement of the athletic ability.
이러한 의미에서 본 발명에서의 감초 추출물은 바람직하게는 열수 추출물과, 에탄올 추출물 또는 초임계 추출물의 혼합 추출물이 보다 적합하다. 수율의 극대화를 위하여 감초를 열수로 추출하여 1차 추출물을 얻은 후, 상기 1차 추출과정에서 얻은 침전물을 에탄올 등 또는 초임계 추출방법에 의해 재차 추출하는 것에 의해 글리시리진과 글라브리딘이 다량 함유된 추출물을 얻을 수 있다. 마찬가지로 감초를 에탄올 등 또는 초임계 추출방법으로 추출하여 1차 추출물을 얻은 후, 상기 1차 추출과정에서 얻은 침전물을 열수추출 방법에 의해 재차 추출하는 것도 위 경우에서와 같이 활성성분의 수율을 극대화하는 것이 가능하다.In this sense, the licorice extract in the present invention is preferably a mixed extract of hot water extract, ethanol extract or supercritical extract. To maximize the yield, licorice is extracted with hot water to obtain a primary extract, and the precipitate obtained in the first extraction process is extracted again by ethanol or a supercritical extraction method, which contains a large amount of glycyrrhizin and glabridine. Extracts can be obtained. Likewise, licorice may be extracted by ethanol or the like, using a supercritical extraction method to obtain a primary extract, and then extracting the precipitate obtained in the primary extraction process by hot water extraction method to maximize the yield of the active ingredient as in the above case. It is possible.
본 발명에서는 각 경우에서의 2차 추출과정에서 얻어진 침전물에 헥산, 클로로포름, 또는 에틸아세테이트로 재차 추출한 추출물을 더 포함하는 것이 바람직하다. 이들 추출물은 전체 조성물의 중량대비 0.1 내지 10 중량%의 범위에서 첨가되어질 수 있으며, 이들 추출물을 추가로 첨가한 실험군에서 동일함량 대비 타 조성물군에 비하여 지구력 내지 운동능력의 개선효과가 보다 우수한 것으로 나타났다.In the present invention, the precipitate obtained in the second extraction process in each case preferably further includes an extract extracted again with hexane, chloroform, or ethyl acetate. These extracts may be added in the range of 0.1 to 10% by weight relative to the total weight of the composition, and in the experimental group to which these extracts were additionally added, the effect of improving endurance or exercise ability was higher than that of other composition groups. .
본 발명의 조성물은 상기한 지구력 내지 운동능력의 개선효과 외에 비만억제활성을 더욱 보강하기 위해 얼레지 추출물을 더 포함할 수 있다. 얼레지 추출물은 열수추출물 또는 에탄올 등 추출물일 수 있으며, 본 발명자의 실험에 의하면 운동능력을 저해함이 없이 비만억제활성이 우수한 것으로 확인되었다. 이러한 얼레지 추출물은 전체 조성물의 함량 대비 1 내지 10 중량%의 범위에서 첨가되는 것이 좋다.
The composition of the present invention may further include an extract of Alzali to further reinforce the anti-obesity activity in addition to the above-mentioned endurance to the improvement of exercise ability. The extract may be a hot water extract or an extract such as ethanol, according to the experiments of the present inventors were found to have excellent anti-obesity activity without inhibiting the exercise ability. Such Alge extract is preferably added in the range of 1 to 10% by weight relative to the total content of the composition.
본 발명에 따른 조성물은 약제, 식품 및 음료 등에 다양하게 이용될 수 있다. 본 발명의 추출물을 첨가할 수 있는 식품으로는, 각종 식품류, 예를 들어, 음료, 껌, 차, 비타민 복합제, 건강보조 식품류 등이 있으며, 환제, 분말, 과립, 침제, 정제, 캡슐 또는 음료인 형태로 사용할 수 있다. 이때, 식품 또는 음료 중의 상기 추출물의 양은 일반적으로 본 발명의 건강식품 조성물의 경우 전체 식품 중량의 0.05 내지 30 중량%로 가할 수 있으며, 건강음료 조성물의 경우 100 ㎖를 기준으로 0.05 내지 30 g 가할 수 있다.The composition according to the present invention can be used in a variety of drugs, food and beverages. Foods to which the extract of the present invention may be added include various foods, for example, beverages, gums, teas, vitamin complexes, dietary supplements, and the like, which are pills, powders, granules, tablets, tablets, capsules or beverages. Available in form. At this time, the amount of the extract in the food or beverage can be added to 0.05 to 30% by weight of the total food weight in the case of the health food composition of the present invention, 0.05 to 30 g based on 100 ml for the health beverage composition can be added. have.
본 명세서에서 사용될 수 있는 식품보조첨가제는 당업계에 통상적인 식품첨가제, 예를 들어 향미제, 풍미제, 착색제, 충진제, 안정화제 등을 포함한다. 본 발명에 따른 건강 음료 조성물은 지시된 비율로 필수 성분으로서, 상기추출물을 외에 첨가되는 성분에 특별한 제한은 없으며 통상의 음료와 같이 여러 가지 향미제 또는 천연 탄수화물 등을 추가 성분으로서 함유할 수 있다. 상기 천연 탄수화물의 예로는 단당류, 예를 들어, 포도당, 과당 등; 이당류, 예를 들어 말토스, 슈크로스 등; 다당류, 예를 들어 덱스트린, 시클로덱스트린 등; 과 같은 통상적인 당 및 자일리톨, 솔비톨, 에리트리톨 등의 당알콜이다. 상술한 것 이외의 향미제로서 천연 향미제(타우마틴, 스테비아 추출물(예를 들어 레바우디오시드 A, 글리시르히진 등)) 및 합성 향미제(사카린, 아스파르탐 등)를 사용하는 것도 좋다. 상기 천연 탄수화물의 비율은 본 발명의 조성물 100 ㎖당 일반적으로 약 0.5 내지 30 g이다.Food additives that can be used herein include food additives customary in the art, such as flavorings, flavors, colorants, fillers, stabilizers, and the like. The health beverage composition according to the present invention is an essential ingredient in the proportions indicated, and there is no particular limitation on the ingredients to be added to the extract other than the above extract, and it may contain various flavors or natural carbohydrates, etc. as additional ingredients, as in general beverages. Examples of the natural carbohydrates include monosaccharides such as glucose, fructose, and the like; Disaccharides such as maltose, sucrose and the like; Polysaccharides such as dextrin, cyclodextrin and the like; Common sugars such as and sugar alcohols such as xylitol, sorbitol, and erythritol. As flavoring agents other than those described above, natural flavoring agents (tautin, stevia extract (e.g., Rebaudioside A, glycyrrhizin, etc.) and synthetic flavoring agents (saccharin, aspartame, etc.) may be used. . The proportion of such natural carbohydrates is generally about 0.5 to 30 g per 100 ml of the composition of the present invention.
상기 외에 본 발명의 지구력 내지 운동능력 증진용 조성물은 다양한 영양제, 비타민, 광물(전해질), 합성 풍미제 및 천연 풍미제 등의 풍미제, 착색제 및 충진제(치즈, 초콜릿 등), 펙트산 및 그의 염, 알긴산 및 그의 염, 유기산, 보호성 콜로이드 증점제, pH 조절제, 안정화제, 방부제, 글리세린, 알콜, 탄산 음료에 사용되는 탄산화제 등을 함유할 수 있다.In addition to the above, the endurance-exercise enhancing composition of the present invention includes various nutrients, vitamins, minerals (electrolytes), synthetic flavors and natural flavoring agents, colorants and fillers (cheese, chocolate, etc.), pectic acid and salts thereof. , Alginic acid and salts thereof, organic acids, protective colloidal thickeners, pH adjusters, stabilizers, preservatives, glycerin, alcohols, carbonation agents used in carbonated drinks and the like.
그밖에 본 발명의 조성물은 천연 과일 쥬스 및 과일 쥬스 음료 및 야채 음료의 제조를 위한 과육을 함유할 수 있다. 이러한 성분은 독립적으로 또는 조합하여 사용할 수 있다. 이러한 첨가제의 비율은 특별히 한정되지는 않지만 본 발명의 조성물 100 중량부에 대하여 0 내지 약 10 중량부의 범위에서 선택되는 것이 일반적이다.In addition, the composition of the present invention may contain a natural fruit juice and a pulp for the production of fruit juice drinks and vegetable drinks. These components can be used independently or in combination. The ratio of such additives is not particularly limited but is generally selected from 0 to about 10 parts by weight based on 100 parts by weight of the composition of the present invention.
본 발명의 상기 감초 추출물을 유효성분으로 함유하는 지구력 내지 운동능력 증진용 조성물은 목적하는 바에 따라 비경구 투여하거나 경구 투여할 수 있으며, 하루에 체중 1㎏ 당 0.001 내지 5g의 양을 1 내지 수회에 나누어 투여할 수 있다. 특정 환자에 대한 투여용량 수준은 환자의 체중, 연령, 성별, 건강상태, 식이, 투여시간, 투여 방법, 흡수율, 질환의 중증도 등에 따라 변화될 수 있다.The composition for enhancing endurance to exercise ability containing the licorice extract of the present invention as an active ingredient may be parenterally or orally administered as desired, and the amount of 0.001 to 5 g per 1 kg of body weight per day may be 1 to several times. It can be administered separately. Dosage levels for a particular patient may vary depending on the patient's weight, age, sex, health condition, diet, time of administration, mode of administration, absorption, severity of the disease, and the like.
이하 본 발명의 내용을 실시예에 의해 보다 상세하게 설명하기로 한다. 다만 이들 실시예는 본 발명의 내용을 이해하기 위해 제시되는 것일 뿐 본 발명의 권리범위가 이들 실시예에 한정되어지는 것으로 해석되어져서는 아니된다.
Hereinafter, the content of the present invention will be described in more detail with reference to Examples. However, these examples are only presented to understand the content of the present invention, and the scope of the present invention should not be construed as being limited to these embodiments.
<실시예 1> 추출용매별 조추출물의 제조Example 1 Preparation of Crude Extracts for Different Solvents
추출용매의 극성에 따라 용출되는 목적 기능 성분의 변화를 측정하고자 감초의 열수 추출, 95% 에탄올 추출 및 초임계 추출을 실시하였다. 추출용매에 따른 추출조건 및 수율은 표 1과 같다.Hot water extraction, 95% ethanol extraction and supercritical extraction of licorice were carried out to measure the change in the target functional components eluted according to the polarity of the extraction solvent. The extraction conditions and yields according to the extraction solvent are shown in Table 1.
극성차이가 대비되는 두 가지 용매 (열수, 에탄올)와 초임계추출물에 있어서의 기능성분 용출의 변화를 확립된 동시 분석 조건을 활용하여 HPLC 분석을 통해 확인하고 (도 1), 이를 정량화 하여 기능성분 함유량의 차이를 측정하였다 (도 2).Changes in functional component elution in two solvents (hot water, ethanol) and supercritical extracts with contrasting polarities were confirmed through HPLC analysis using established simultaneous analytical conditions (Fig. 1), and quantified for functional ingredients. The difference in content was measured (FIG. 2).
즉 극성용매를 사용한 열수 추출물의 경우, 글리시리진산(glycyrrhizic acid)의 함량이 뚜렷이 높았으며 비극성 용매를 사용한 95% 에탄올 추출물의 경우는 글리시리진산의 용출은 매우 낮았고 글라브리딘이 소량 용출되었다. 이와 달리, 초임계 추출의 경우, 글리시리진산의 함량은 낮고 글라브리딘이 다량 용출됨을 확인하였다.
That is, the content of glycyrrhizic acid was obviously high in the hydrothermal extract using the polar solvent, and the elution of the glycyrilic acid was very low in the 95% ethanol extract using the nonpolar solvent, and a small amount of glybridine was eluted. In contrast, in the case of supercritical extraction, it was confirmed that the content of glycyrrhizinic acid was low and glabridine was eluted.
<실험예 2> 비만 동물에서의 지구력 증강 효능 평가Experimental Example 2 Evaluation of Endurance Enhancement Effect in Obese Animals
감초 유래의 항비만 효능 및 운동 수행능 증가의 효능을 동시에 지니는 소재를 개발하기 위해 추출용매별 감초 추출물 급여가 비만 동물의 체중 및 운동 수행능에 미치는 영향을 측정하였다. 4주령의 마우스를 구입하여 1주간의 적응 후 정상식이 급여군과 고지방 식이 급여군으로 나누어 4주 동안 실험 식이를 급여하였다. 4주간의 고지방 식이 급여 결과, 고지방 식이 급여로 인한 체중 증가가 나타나지 않는 마우스 (resistant to high fat diet-induced body weight increase)를 실험군에서 탈락시켜 실험동물 자체 특성의 차이를 배제하고자 하였다.In order to develop a material having both anti-obesity effects from licorice and an effect of increasing exercise performance, the effect of licorice extract supplementation per extract solvent on the weight and exercise performance of obese animals was measured. Four-week-old mice were purchased for one week of adaptation, then divided into two groups: normal diet and high fat diet, and fed experimental diet for four weeks. As a result of 4 weeks of high fat diet, the mice without resistant to high fat diet-induced body weight increase were eliminated from the experimental group.
선별 후 각 그룹별로 10마리씩 배치하여 6그룹으로 나누어 9주 동안 실험식이를 급여하였다. 6군의 구성은 정상식이 급여군 (N), 고지방 식이를 급여한 운동군 (C-E), 감초 에탄올 추출물 1% 포함 고지방 식이를 급여한 운동군 (E-E), 감초 열수 추출물 1% 포함 고지방 식이를 급여한 운동군 (W-E), 감초 초임계 추출물 0.1% 또는 0.25 % 포함 고지방 식이를 급여한 운동군 (각각 SL-E, SH-E)으로 하였다.After screening, 10 animals were placed in each group, divided into 6 groups, and fed the experimental diet for 9 weeks. The six groups consisted of the normal diet group (N), the exercise group fed a high fat diet (CE), the exercise group fed a high fat diet (EE) and the high fat diet containing 1% licorice hot water extract. The exercise group fed (WE), liquor supercritical extract 0.1% or 0.25% high fat diet containing the exercise group (SL-E, SH-E, respectively).
실험 시작 후 3, 6, 9 주에 트레드밀(treadmill) 운동을 시켰다. 15ㅀ 경사로 훈련은 첫날 5m/min의 속도로 15분간, 10m/min 5분간, 이틀째 5m/min의 속도로 10분간, 10m/min 10분간 시켰으며 시험날인 셋째날에는 10 m/min 으로 20분간 운동 후 2분마다 1 m/min으로 속도를 증가시켰다. 최대 운동 수행능은 운동을 멈춘 후 그리드(grid)에서 10초 이상 머무를 때까지의 달린 거리로 환산하였다.
Treadmill exercise was performed at 3, 6 and 9 weeks after the start of the experiment. 15 ㅀ ramp training was conducted for 15 minutes, 10m / min for 5 minutes, 10m / min for 10 minutes, 10m / min for 10 minutes at the speed of 5m / min on the first day, and 20m for 10 minutes on the third day of the test. The speed was increased to 1 m / min every two minutes after exercise. Maximum exercise performance was converted to distance run after stopping exercise and staying on the grid for at least 10 seconds.
(가) 체중 변화 및 식이 섭취량(A) Weight change and dietary intake
9주간의 실험기간 동안의 체중변화를 주별로 측정한 결과 W-E, SL-E 및 SH-E 그룹에서 유의적인 체중의 감소 경향이 나타났다 (도 3).Weekly measurements of body weight changes during the 9-week experimental period showed significant weight loss trends in the W-E, SL-E and SH-E groups (FIG. 3).
9주간의 실험 기간 동안 체중 증가량을 비교한 결과 N-E군은 7.8g 증가 (비운동 군에 비해 0.85g 감소)한 반면 C-E 그룹은 14.02g 증가 (비운동군 실험군에 비해 0.1g 감소)하였다. W-E 및 SH-E 그룹은 체중 증가가 각각 8.96g, 6.86g 으로 유의적으로 감소하였으며 이는 비운동군의 8.76g, 9.14와 비교시 SH-E 그룹의 경우 운동에 의한 체중 감소 효능이 가장 높게 나타났다 (도 4). 그러나 실험기간 중의 식이 섭취량은 실험군별 차이는 나타나지 않아 (도 5) 식이 섭취량 감소에 따른 체중증가가 아닌 것으로 사료되었다.
As a result of comparing the weight gain during the 9-week experiment period, the NE group increased by 7.8g (0.85g decrease compared to the non-exercise group) while the CE group increased by 14.02g (0.1g decrease compared to the non-exercise group). The WE and SH-E groups showed significant decreases in weight gain of 8.96g and 6.86g, respectively, compared to 8.76g and 9.14 in the non-exercise group. 4). However, the dietary intake during the experimental period did not show a difference between the experimental groups (FIG. 5), and it was considered that the weight gain was not due to the decrease in dietary intake.
(나) 최대 운동 수행능 (B) Maximum athletic performance
감초 추출물의 급여가 비만 동물의 운동 수행능에 미치는 영향을 측정하고자, 실험식이 급여 3, 6, 9주 후에 트레드밀 운동을 통해 최대 운동 수행능을 마우스가 지칠 때까지 이동한 거리 (distance to exhaustion)로 측정하였다. 그 결과 실험 식이 급여 6주 후 E-E, W-E 및 SH-E에서, 9주의 경우는 W-E 및 SH-E 그룹에서 운동 수행능의 증가가 나타났으며 특히, 9주의 SH-E 그룹의 경우 C-E에 비해 2.3 배 이상, N-E 그룹에 비해 1.3배 이상 최대 이동거리가 증가하여 지구력 증진에 매우 효과적으로 사료되었다 (도 6).
To determine the effect of licorice extract on exercise performance in obese animals, the experimental diet was measured by distance to exhaustion after 3, 6, and 9 weeks of feeding through the treadmill exercise. Measured. As a result, the exercise performance was increased in the EE, WE and SH-E after 6 weeks of dietary supplementation, and in the WE and SH-E group of 9 weeks, especially in the 9-week SH-E group. The maximum movement distance was increased by 2.3 times or more and 1.3 times compared to the NE group, and thus, it was considered to be very effective for improving endurance (FIG. 6).
(다) 장기 무게(C) long-term weight
9주간의 실험식이 급여 후 각 그룹별 마우스의 장기무게 (간, 부고환 지방, 신장주위 지방 및 갈색지방)의 비교 결과 (도 7), 간의 경우 고지방 식이 급여로 인한 무게의 증가가 모든 감초 추출물 급여 그룹에서 유의적으로 감소하였다. 백색지방인 부고환 지방 및 신장주위지방의 경우 W-E 및 SH-E 그룹에서 C-E에 비해 유의적으로 감소하였다. 갈색지방의 경우는 모든 감초 추출물 급여 그룹에서 모두 통계적으로 유의한 감소를 보였다.
Comparison of the long-term weight (liver, epididymal fat, peri-renal fat and brown fat) of mice in each group after 9 weeks of dietary feeding (Fig. 7) Significantly decreased in the group. The epididymal and peri-renal fats, white fats, were significantly decreased in the WE and SH-E groups compared to CE. Brown fat was significantly decreased in all licorice extract fed groups.
(라) 조직학적 분석(D) histological analysis
간 (Liver), 부고환 지방 (WAT) 및 갈색지방 (BAT)의 조직 관찰을 위해 포르말린 고정 조직 절편의 H&E stain 결과, 간의 경우, 장기 무게 측정시 나타났던 경향과 같이, 감초 추출물이 포함된 고지방 식이의 급여시 고지방 식이 단독 급여군에 비해 지방간의 병변이 뚜렷하게 억제된 것으로 관찰되었다. 부고환 지방의 경우는 감초 추출물 급여시 지방세포의 크기 감소가 관찰되었으며 갈색지방의 경우, 조직 무게의 감소가 세포내 지방 침착 억제에 의한 것임을 확인할 수 있었다 (도 8).
H & E staining of formalin fixed tissue sections for histological observations of liver, epididymal fat (WAT) and brown fat (BAT), high fat diet with licorice extract, as shown in the liver, tendency when weighing organs It was observed that fatty liver lesions were significantly suppressed in the high-fat diet alone. In the case of epididymal fat, a decrease in the size of adipocytes was observed when licorice extract was fed, and in the case of brown fat, the decrease in tissue weight was confirmed by the inhibition of intracellular fat deposition (FIG. 8).
(마) 혈중 지질 변화(E) blood lipid changes
감초 추출물 급여가 혈중 지질 함량에 미치는 영향을 측정한 결과 (도 9), N-E에 비해 C-E군에서 TG, TC, HDL-C 및 LDL-C의 유의적 증가가 관찰되었다. TG의 경우는 W-E, SL-E 군에서만 유의적으로 감소되었으나 TC, LDL-C 및 NEFA의 경우는 모든 감초 추출물 급여 군에서 유의적으로 감소하여 혈중 지질 조절 효능이 높은 것으로 사료되었다.
As a result of measuring the effect of licorice extract on the blood lipid content (FIG. 9), a significant increase in TG, TC, HDL-C and LDL-C was observed in the CE group compared to the NE. TG was significantly decreased in the WE, SL-E group, but TC, LDL-C, and NEFA were significantly decreased in all licorice extract fed groups, suggesting high blood lipid control efficacy.
(바) 혈당, 혈청 호르몬 및 효소 활성(F) blood sugar, serum hormone and enzyme activity
혈액에서의 혈당의 그룹별 차이는 관찰되지 않았으며 이는 절식 없이 최대 운동 수행능 평가 후 채혈하였기 때문으로 사료되었다. 혈중 렙틴(leptin)은 감초 추출물 투여군 모두에서 유의적으로 감소하였으며 특히, 지구력 증진 효과가 뛰어났던 SH-E 군에서 가장 낮은 수치를 보였다. 글리코겐 또는 포도당이 분해되어 ATP를 형성하는 과정에서 세포내에 충분한 양의 산소가 공급되지 못하면 혐기적 대사의 결과로 젖산이 축적됨에 따라 LDH의 활성이 증가하게 되며 또한 LDH는 근육손상의 대표적 마커이다. C-E 그룹에서는 N-E 그룹에 비해 혈청 LDH의 유의적 증가가 나타났으며 감초 추출물 급여 군에서 모두 효과적으로 억제된 것이 관찰되었다. 즉 감초 추출물 급여시 지구력 운동 결과 유도되는 근육 손상에 대해 보호 작용이 있는 것으로 사료되었다. 항산화 효소인 SOD의 경우 C-E 군에 비해 감초 추출물을 급여한 모든 군에서 증가하는 경향을 보였으나 유의적이지는 않았다 (표 2).No differences in blood glucose were observed in the blood. Blood leptin was significantly decreased in all licorice extract groups, especially in the SH-E group, which had a superior endurance effect. If glycogen or glucose is decomposed to form ATP and insufficient oxygen is supplied to the cells, LDH activity increases as lactic acid accumulates as a result of anaerobic metabolism, and LDH is a representative marker of muscle injury. In the C-E group, there was a significant increase in serum LDH compared to the N-E group. In other words, the licorice extract was found to be protective against muscle damage induced by endurance exercise. Antioxidant SOD tended to increase in all groups fed licorice extract compared to C-E group, but not significant (Table 2).
(사) 간 지질 변화Liver lipid change
간 조직의 총 지방량, TG, TC 및 NEFA를 분석한 결과 hepatic total lipid, hepatic TG, hepatic TG 및 NEFA에 대해, 감초 추출물은 고지방 식이 급여에 의한 혈중 지질 상승을 매우 효과적으로 억제하는 것으로 나타났다 (도 10).
Analysis of total fat mass, TG, TC, and NEFA in liver tissue showed that for hepatic total lipid, hepatic TG, hepatic TG, and NEFA, licorice extract effectively inhibited blood lipid elevation by high fat diet (FIG. 10). ).
(아) 간의 운동 마커 변화(H) Movement marker change of liver
무산소 운동시 ATP를 재합성하는데 필요한 크레아틴 포스페이트(creatine phosphate) 합성을 촉매하는 효소인 CPK는 근육손상의 마커로도 알려져 있다. C-E 그룹에서 상승한 CPK는 감초 추출물 급여 군에서 유의적으로 감소하였다. 간 글리코겐의 경우 C-E 그룹에서 현저히 높은 것은 고지방 식이 급여로 인해 과잉 에너지가 글리코겐의 형태로 간에 저장되어 지방간 병변으로 발전했기 때문이다. 이 외에도 최대 운동 후 간을 적출하여 상대적으로 적은 양의 운동을 수행한 C-E 그룹은 간의 글리코겐의 사용을 많이 하지 않은 것도 하나의 원인으로 사료되었다 (도 11).
CPK, an enzyme that catalyzes the synthesis of creatine phosphate required to resynthesize ATP during anaerobic exercise, is also known as a marker of muscle damage. CPK elevated in the CE group was significantly decreased in the licorice extract fed group. The hepatic glycogen is significantly higher in the CE group because of the high-fat diet, excess energy is stored in the liver in the form of glycogen to develop fatty liver lesions. In addition, the CE group that performed a relatively small amount of exercise after extracting the liver after the maximum exercise was considered to be one of the reasons that the hepatic glycogen was not used much (FIG. 11).
(자) 근육의 운동 마커 변화(M) Changes in the movement markers of muscles
최대 운동 수행 후 근육내 젖산 및 글리코겐의 농도를 측정하였음 (도 12). 젖산은 무산소 운동 중에 근세포질에 축적되는 피로물질로서 운동에 의해 체내에 축적시 체내 환경의 산성화를 통해 운동에너지의 급원이 되는 당신생의 억제를 유도한다. C-E 그룹의 경우 근육의 젖산 축적이 증가하였으나 감초 추출물을 급여한 운동군에서는 젖산의 축적이 감소되는 경향을 보였다.Muscle concentrations of lactic acid and glycogen were measured after maximal exercise was performed (FIG. 12). Lactic acid is a fatigue substance that accumulates in myocytes during anaerobic exercise, and when it accumulates in the body by exercise, it induces the suppression of your life, which is a source of kinetic energy through acidification of the body environment. In the C-E group, muscle lactic acid accumulation increased, but in the exercise group fed licorice extract, lactic acid accumulation tended to decrease.
근육의 글리코겐 농도는 지구력 운동수행능력에 영향을 미치는 요인으로 알려져 있는데, 본 실험 결과 감초추출물 투여 군에서 C-E 군에 비해 오히려 근육 내 글리코겐 농도가 감소한 것으로 나타났다. 이는 마우스를 탈진시까지 운동을 시킨 후 근육을 채취하였는데, 탈진시까지의 운동거리가 C-E 군에서 다른 실험군에 비해 유의적으로 짧았기 때문에 상대적으로 근육의 글리코겐이 덜 고갈되었기 때문으로 사료되었다.
Muscle glycogen concentration is known as a factor affecting endurance exercise performance. The results of this experiment showed that the licogen extract group decreased muscle glycogen concentration in comparison with CE group. This was because the muscles were collected after exercising the mice until exhaustion, because the exercise distance until exhaustion was significantly shorter in the CE group than in the other experimental groups.
(차) Muscle fiber type transition(Tea) Muscle fiber type transition
속근 (fast and glycolytic)의 type II 근육의 대표적 근육인 비복근 (gastronemius m.)의 운동 후 변화를 측정하고자 지근 (slow and aerobic type I muscle) 마커인 트로포닌 I(troponin I)과 속근 마커인 MyHCIIb의 유전자 발현을 측정한 결과 운동 후 감초 추출물 급여군에서 속근이 줄어들고 지근이 증가하는 경향을 나타냈다 (도 13).
To measure post-exercise changes in gastronemius m., A typical muscle of fast and glycolytic type II muscles, troponin I, a slow and aerobic type I muscle marker, and MyHCIIb, a fast muscle marker As a result of measuring the gene expression of the licorice extract after exercise showed a tendency to decrease the fast muscles and increase the muscles (Fig. 13).
(카) 호흡량 및 호흡률 변화(K) Changes in respiratory volume and respiratory rate
체중변화에 미치는 호흡율 영향을 알아보기 위해, 각 그룹의 마우스를 저녁 7시부터 오전 7시까지 12시간 동안 calorimetry로 VO2, VCO2 및 RQ (respiroatory quotient, 호흡율)를 측정한 결과는 도 14와 같다. N 그룹은 C 그룹에 비해 RQ가 상승하는 경향을 보였으나 유의적이지는 않았다. W-E 그룹의 경우 VO2 및 VCO2 모두 증가되어 RQ는 유지되었다. SL 및 SH 그룹도 VO2 및 VCO2 모두 증가되는 경향을 보였으나 유의적 차는 없었다.
To determine the effect of respiratory rate on body weight change, mice in each group measured VO 2 , VCO 2 and RQ (respiroatory quotient) by calorimetry for 12 hours from 7 pm to 7 am. same. N group tended to increase RQ compared to C group, but it was not significant. VO 2 and VCO 2 for WE group All increased and RQ maintained. SL and SH groups are also VO 2 and VCO 2 All tended to increase but there was no significant difference.
<실험예 3>Experimental Example 3
얼레지 열수추출물 5 중량%를 포함하는 본 발명의 지구력 내지 운동능력 증진용 조성물(5중량%의 감초 열수추출물 함유, A)을 성숙한 지방세포에 48시간 처리한 후 DAPI 염색하여 지방세포의 세포사멸 유도 효능을 평가한 결과 지방세포의 세포사멸이 얼레지 열수추출물을 함유하지 않은 본 발명의 지구력 내지 운동능력 증진용 조성물(C)에 비하여 증가한 것으로 확인되었다 (도 15).Induction of apoptosis of fat cells by treatment with mature fat cells for 48 hours after the endurance-exercise enhancing composition (containing 5% by weight licorice hot water extract, A) of the present invention comprising 5% by weight of hot water extract As a result of evaluating the efficacy, it was confirmed that the apoptosis of the adipocytes was increased compared to the endurance-exercise enhancing composition (C) of the present invention, which did not contain the oleic hot water extract (FIG. 15).
상기와 같이, 본 발명의 바람직한 실시 예를 참조하여 설명하였지만 해당 기술 분야의 숙련된 당업자라면 하기의 특허청구범위에 기재된 본 발명의 사상 및 영역으로부터 벗어나지 않는 범위 내에서 본 발명을 다양하게 수정 및 변경시킬 수 있음을 이해할 수 있을 것이다.As described above, it has been described with reference to a preferred embodiment of the present invention, but those skilled in the art various modifications and changes of the present invention without departing from the spirit and scope of the invention described in the claims below I can understand that you can.
Claims (8)
감초 추출물은 열수 추출물인 것을 특징으로 하는 지구력 내지 운동능력 증진용 조성물.The method of claim 1,
Licorice extract is a composition for enhancing endurance to athletic performance, characterized in that the hot water extract.
감초 추출물은 에탄올 추출물 또는 에탄올을 추출용매로 하는 초임계 추출물인 것을 특징으로 하는 지구력 내지 운동능력 증진용 조성물.The method of claim 1,
Licorice extract is a composition for enhancing endurance or athletic performance, characterized in that the supercritical extract using an ethanol extract or ethanol as an extract solvent.
감초 추출물은 열수 추출물과, 상기 열수추출과정에서 얻어진 침전물을 대상으로 하는 에탄올 추출물의 혼합물인 것을 특징으로 하는 지구력 내지 운동능력 증진용 조성물.The method of claim 1,
Licorice extract is a composition for enhancing endurance or athletic ability, characterized in that the mixture of hot water extract and ethanol extract for the precipitate obtained in the hot water extraction process.
감초 추출물은 에탄올 추출물과, 상기 에탄올 추출과정에서 얻어진 침전물의 열수추출물로 이루어지는 혼합물인 것을 특징으로 하는 지구력 내지 운동능력 증진용 조성물.The method of claim 1,
Licorice extract is a composition for improving endurance to athletic performance, characterized in that the mixture consisting of ethanol extract, and hot water extract of the precipitate obtained in the ethanol extraction process.
얼레지 추출물을 더 포함하는 것을 특징으로 하는 지구력 내지 운동능력 증진용 조성물.The method of claim 1,
Composition for improving endurance to athleticism, characterized in that it further comprises an extract.
상기 열수 추출과정에서 얻어진 침전물을 에탄올추출 또는 초임계 추출하여 글라브리딘을 활성성분으로 주로 함유하는 제2추출물을 얻는 단계; 및
상기 제1추출물과 제2추출물을 혼합하는 단계;
를 포함하는 지구력 내지 운동능력 증진용 감초추출물의 제조방법.Extracting licorice with hot water to obtain a first extract containing mainly glycyrizine as an active ingredient;
Ethanol extraction or supercritical extraction of the precipitate obtained in the hydrothermal extraction process to obtain a second extract containing mainly glabridine as an active ingredient; And
Mixing the first extract and the second extract;
Method of producing a licorice extract for improving endurance or athletic performance comprising a.
상기 에탄올 추출과정에서 얻어진 침전물을 열수로 추출하여 글리시리진을 활성성분으로 주로 함유하는 제2추출물을 얻는 단계; 및
상기 제1추출물과 제2추출물을 혼합하는 단계;
를 포함하는 지구력 내지 운동능력 증진용 감초추출물의 제조방법.Ethanol extraction or supercritical extraction of licorice to obtain a first extract containing mainly glabridine as an active ingredient;
Extracting the precipitate obtained in the ethanol extraction process with hot water to obtain a second extract mainly containing glycyrrhizin as an active ingredient; And
Mixing the first extract and the second extract;
Method of producing a licorice extract for improving endurance or athletic performance comprising a.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020100065690A KR20120005111A (en) | 2010-07-08 | 2010-07-08 | Athletic ability enhancing composition comprising licorice extracts and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020100065690A KR20120005111A (en) | 2010-07-08 | 2010-07-08 | Athletic ability enhancing composition comprising licorice extracts and preparation method thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020130106321A Division KR101436753B1 (en) | 2013-09-04 | 2013-09-04 | Anti obesity composition comprising licorice extracts and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20120005111A true KR20120005111A (en) | 2012-01-16 |
Family
ID=45611351
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020100065690A KR20120005111A (en) | 2010-07-08 | 2010-07-08 | Athletic ability enhancing composition comprising licorice extracts and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| KR (1) | KR20120005111A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20190099960A (en) * | 2018-02-20 | 2019-08-28 | 한국식품연구원 | Composition for preventing, improving or treating muscular disease comprising Red Paprika extract or Capsanthin |
| KR20200145718A (en) * | 2019-06-19 | 2020-12-30 | 영남대학교 산학협력단 | Composition for preventing or treating muscular diseases |
-
2010
- 2010-07-08 KR KR1020100065690A patent/KR20120005111A/en active Application Filing
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20190099960A (en) * | 2018-02-20 | 2019-08-28 | 한국식품연구원 | Composition for preventing, improving or treating muscular disease comprising Red Paprika extract or Capsanthin |
| KR20200145718A (en) * | 2019-06-19 | 2020-12-30 | 영남대학교 산학협력단 | Composition for preventing or treating muscular diseases |
| KR20200145717A (en) * | 2019-06-19 | 2020-12-30 | 영남대학교 산학협력단 | Composition for preventing or treating muscular diseases |
| KR20200145716A (en) * | 2019-06-19 | 2020-12-30 | 영남대학교 산학협력단 | Composition for preventing or treating muscular diseases |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20110052730A1 (en) | Leaves Extract of Panax sp., a Process of Making the Same and Uses Thereof | |
| KR102005423B1 (en) | Composition comprising extract of Salvia miltiorrhiza Radix for preventing or treating of visceral fat | |
| KR101523663B1 (en) | A composition for preventing or treating fatty liver disease or obesity, comprising a extract of Arctium lappa Linne, Glycyrrhiza uralensis Fischer, Zingiberis rhizoma Crudus and Magnoliae Cortex | |
| KR20120002131A (en) | Composition for treating or preventing obesity containing curcuma longa extract | |
| KR101685438B1 (en) | A composition comprising an extract of Hippophae rhamnoides for improving physical fatigue, and exercise performance ability | |
| KR20160141027A (en) | Phamaceutical composition or healthy food comprising water extracts from Pleurotus eryngii var. ferulea (Pf.). for treating or preventing metabolic disorder | |
| KR101446528B1 (en) | Vinegar Composition Fermented with Black Garlic and Preparation Method Thereof | |
| KR101160088B1 (en) | Herbal extracts composition for the prevention of alcoholic fatty liver, hyperlipidemia and hangover | |
| KR20120005111A (en) | Athletic ability enhancing composition comprising licorice extracts and preparation method thereof | |
| KR101050003B1 (en) | Composition for inhibiting obesity, containing the extract as an active ingredient | |
| KR20100130020A (en) | A composition comprising novel black ginseng without tumor promoting agents such as benzopyran and the extract thereof obtained by novel process | |
| KR20190001112A (en) | Anti-obesity composition comprising Protaetia brevitarsis seulensis larva extracts | |
| KR101436753B1 (en) | Anti obesity composition comprising licorice extracts and preparation method thereof | |
| KR101344189B1 (en) | A Composition comprising an extract of fermented or non-fermented Lonicerae Flos and Citri Reticulatae Pericarpium for treating or preventing obesity | |
| KR101597187B1 (en) | A composition comprising the extract of Melia azedarach showing anti-cancer activity against stomach tumor | |
| KR101791574B1 (en) | Pharmaceutical composition for preventing or treating female menopausal disorder comprising an extract of black rice aleurone layer | |
| KR20200049437A (en) | Composition for increase of muscular functions or exercise capacity comprising Vigna unguiculata (L.) Walp., Vicia faba L., or Dolichos lablab L. | |
| KR101297034B1 (en) | Composition for preventing and treating metabolic syndrome comprising eel extract | |
| KR102599530B1 (en) | A composition for weight control comprising benzopyran | |
| KR101991746B1 (en) | Agent for improvement of cathechin bioavailability | |
| KR102251889B1 (en) | Composition for increase of muscular functions or exercise capacity comprising Vigna unguiculata (L.) Walp., Vicia faba L., or Dolichos lablab L. | |
| EP4162814A1 (en) | Composition for fatigue recovery | |
| KR20130130411A (en) | Composition for enhancing muscular strength and stamina comprising extract of hazel pollen as effective component | |
| KR101187455B1 (en) | Anti-osteoporotic effect of Opuntia humifusa | |
| KR20170055366A (en) | A composition for preventing or treating obesity comprising taraxacum coreanum root extract |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A201 | Request for examination | ||
| E902 | Notification of reason for refusal | ||
| E90F | Notification of reason for final refusal | ||
| E601 | Decision to refuse application | ||
| A107 | Divisional application of patent |